Development of Pectin-Poly (Vinyl Pyrrolidone) blend micro beads for controlled release of 5-FU
Keywords:
Pectin, PVP, Micro beads, 5-Fluorouracil, Drug delivery and Colon cancerAbstract
In the present work we developed Pectin-poly (vinyl pyrrolidone) (PC-PVP) based micro beads using oil in water emulsion cross linking method employing Ca+2 as an ionic crosslinker. 5-fluorouracil drug was loaded into these beads via blending method. Various formulations were prepared by varying ratios of PC-PVP, crosslinker and % of 5-FU loading. Micro beads were characterized by Fourier transforms infrared spectroscopy (FTIR), differential scanning calorimetric (DSC), X-Ray diffraction(X-RD) and Scanning electron microscopy (SEM). DSC and XRD studies were performed to understand the crystalline nature of drug after encapsulation into semi IPN micro beads. SEM images gave the beads with smooth surface. FT-IR spectroscopy of micro beads shows to confirm the formation of co-polymerization between the polymers. The encapsulation efficiency was found up to 82% as measured using UV-Visible spectrophotometer. Drug release profiles of the semi IPN micro beads at gastro intestinal tract (GIT) fluids (pH 1.2 and 7.4) confirmed that beads formed are pH-sensitive, resulting controlled release of drug during in vitro dissolution experiments. It has been analyzed with an empirical equation to understand the diffusion nature of drug through the micro beads. Both encapsulation efficiency and release patterns are found to depend on the nature of the cross-linking agent as well as amount of drug loading and % of pectin-PVP. In-vitro release studies indicated that the beads have potentially used for site specific drug delivery for colon cancer.
References
Schmoll HJ, Buchele T, Grothey A. Semin Oncol 1999; 26:589-605.
. Krishnaiah YS, Satyanarayana V, Dinesh Kumar B, Karthikeyan RS. Eur J Pharm Sci 2002;16:185-192.
. Phillips TA, Howell A, Grieve RJ, Welling PG. J Pharm Sci 1980;69:1428-1431.
. Göppert TM, Müller RH. Int J Pharm 2005; 302 (1-2):172-186.
. Heidelberger C, Chaudhuri NK, Danneburg P. Nature 1957; 179 (4561), 663-666.
. Chourasia, MK, Jain SK. J Pharm Pharm Sci 2003; 6 (1): 33-66.
. Wilding IR, Hardy JG, Sparrow RA, Davis SS, Duly PB, English JR. Pharm Res 1992; 9(11):1436-1441.
. Khan MZ, Prebeg Z, Kurjakovic N. J Control Release 1999; 58: 215-222.
. Sinha VR, Kumria R. Int J Pharm 2001; 224:19-38.
. Vandamme TF, Lenourry A, Charrueau C, Chaumeil JC. Carbohydr Polym 2002;48:219-231.
. Rinaudo M. In: Visser J, Voragen AGJ, editors. New York: Elsevier Science; 1996. 15 (1): 21-35.
. Sakai T, Sakamoto T, Hallaert J, Vandamme EJ. Adv Appl Microbiol 1993;39:213-294.
. Thakur BR, Singh RK, Handa AK. Crit Rev Food Sci Nutr 1997;37:47–73.
. Wei He, Qing Du, De-Ying Cao, Bai Xiang, Li-Fang Fan. International Journal of Pharmaceutics 2008; 348(1-2):35–45.
. Qing Luo, Puxiu Wang, Yuqiang Miao, HaibingHe, Xing Tang. Carbohydrate Polymers 2012,87 (4): 2642–2647.
. Madhusudana Rao K, Mallikarjuna B, Krishna Rao KSV, Prabhakar MN, Chowdoji Rao K, Subha M CS. Polym Bull 2012; 68:1905–1919.
. Patel GM, Patel NK, Kansara S. Polymer Inter 1994;35 (1):83-88.
. Sanli O, Ay N, Isiklan N. Eur J Pharm Biopharm 2007;65:204–214.
. J. Siepmann, N.A. Peppas, Adv Drug Deli Rev. 48 (2001) 139-157.
. Ritger PL, Peppas NA. J Control Release 1987;5:37-42.
